Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
5.66
-0.21 (-3.58%)
At close: Apr 10, 2026, 4:00 PM EDT
5.55
-0.11 (-1.94%)
After-hours: Apr 10, 2026, 5:47 PM EDT
Savara Market Cap
Savara has a market cap or net worth of $1.43 billion as of April 10, 2026. Its market cap has increased by 209.33% in one year.
Market Cap
1.43B
Enterprise Value
1.23B
1-Year Change
209.33%
Ranking
Category
Stock Price
$5.66
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $1.43B, an increase of 980.21%. That is a compound annual growth rate of 30.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 1.16B | -5.58% |
| Dec 31, 2025 | 1.23B | 132.85% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
| Apr 28, 2017 | 132.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.52B |
| Ardelyx | 1.52B |
| MBX Biosciences | 1.47B |
| Precigen | 1.47B |
| Nanobiotix | 1.46B |
| Generate Biomedicines | 1.45B |
| Olema Pharmaceuticals | 1.40B |
| Monte Rosa Therapeutics | 1.40B |